rxstat › Classes › Antiglaucoma Preparations And Miotics
Antiglaucoma Preparations And Miotics: shortage status in Canada
15 of the 18 antiglaucoma preparations and miotics rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortageAcetazolamide2 of 3 reported products affected · est. return Jan 1, 2027Widespread shortageLevobunolol2 of 4 reported products affectedWidespread shortagePilocarpine4 of 6 reported products affectedWidespread shortageTimolol6 of 12 reported products affected · est. return Jul 30, 2027Widespread shortageTimolol Brimonidine3 of 3 reported products affected · est. return Oct 2, 2026Widespread shortageTimolol Latanoprost4 of 8 reported products affected · est. return Aug 15, 2026Partial shortageAcetylcholine Chloride1 of 1 reported products affected · est. return Aug 1, 2026Partial shortageBimatoprost1 of 2 reported products affectedPartial shortageBrimonidine2 of 9 reported products affected · est. return Jan 15, 2027Partial shortageDipivefrin1 of 1 reported products affectedPartial shortageDorzolamide1 of 5 reported products affected · est. return Aug 28, 2026Partial shortageLatanoprost4 of 11 reported products affected · est. return Aug 25, 2026Partial shortageTimolol Dorzolamide1 of 11 reported products affected · est. return May 1, 2026Partial shortageTimolol Travoprost1 of 2 reported products affected · est. return Sep 4, 2026Partial shortageTravoprost1 of 5 reported products affectedNo current shortageApraclonidineDiscontinuedBetaxolol0 of 1 reported products affectedNo current shortageMethazolamide
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.